Vimpat and Deltasone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vimpat (lacosamide) and Deltasone (prednisone). Common drug interactions include myalgia among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Vimpat and Deltasone. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

What is Deltasone?

Deltasone has active ingredients of prednisone. eHealthMe is studying from 4,243 Deltasone users. Check the latest studies of Deltasone.



On Jul, 11, 2026

19 people who take Vimpat and Deltasone together, and have interactions are studied.

Vimpat and Deltasone drug interactions.

What are the common drug interactions of Vimpat and Deltasone, by gender? *:

female:

  1. Myalgia (muscle pain)
  2. Neck pain
  3. Oedema (fluid collection in tissue)
  4. Oral pain
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  6. Pain
  7. Photophobia (extreme sensitivity to light)
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

male:

  1. Fall
  2. Back pain
  3. Drug ineffective
  4. Fatigue (feeling of tiredness)
  5. Gait disturbance
  6. Headache (pain in head)
  7. Hypertension (high blood pressure)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Leukocytosis (increased white blood cells)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Vimpat and Deltasone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Photopsia (presence of perceived flashes of light)
  2. Postictal state
  3. Sensory loss (senses loss)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  7. Vision blurred
  8. Lymphocyte count decreased
  9. Migraine with aura (headache with vision weakness)
  10. Moaning (a low, sustained, mournful cry)

30-39:

n/a

40-49:

  1. Cerebellar ataxia (loss of coordination)
  2. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Dysarthria (speech disorder)
  5. Fall
  6. Pain
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Diplopia (double vision)
  9. Encephalitis (inflammation of the brain)
  10. Neuromyopathy (disease of both muscles and nerves)

50-59:

n/a

60+:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Chills (felling of cold)
  4. Constipation
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Diarrhoea
  7. Dizziness
  8. Drug hypersensitivity
  9. Drug intolerance (drug sensitivity)
  10. Dry skin

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 11 people, 57.89%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 36.84%
  3. Rickets (softening of bones): 7 people, 36.84%
  4. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 7 people, 36.84%
  5. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 7 people, 36.84%
  6. Hyperkeratosis (thickening of the outer layer of the skin): 7 people, 36.84%
  7. Insomnia (sleeplessness): 7 people, 36.84%
  8. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 4 people, 21.05%
  9. Juvenile Myoclonic Epilepsy (childhood epilepsy occurring early in morning affecting 12 to 18 years): 4 people, 21.05%
  10. Pain: 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Vimpat and Deltasone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vimpat and Deltasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Deltasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimpat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Deltasone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide and prednisone (the active ingredients of Vimpat and Deltasone, respectively), and Vimpat and Deltasone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: